Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Vinblastine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 10mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 10mg/10mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 30mg/30mL infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 50mg/50mL infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 10mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 1mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine 10mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 30mg/30mL conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 50mg/50mL conventional release solution for infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vinblastine sulfate 10 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vinblastine sulfate 10 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely vinblastine sulfate 10 milligram/10 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely vinblastine sulfate 10 milligram/10 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely vinblastine sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely vinblastine sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Vinblastine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |